Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.34 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.33 |
| ▸ | CDC14B | O60729 | 1/20 | 0.31 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.31 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.31 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22817681 | 1.00 | ALOX5 (0.34) | ALOX5PLA2G2APLA2G4ACDC14BCDC14A | |
| SCHEMBL22817702 | 1.00 | ALOX5 (0.34) | ALOX5PLA2G2APLA2G4ACDC14BCDC14A | |
| SCHEMBL22817962 | 1.00 | ALOX5 (0.34) | ALOX5PLA2G2APLA2G4ACDC14BCDC14A | |
| SCHEMBL22817930 | 1.00 | ALOX5 (0.34) | ALOX5PLA2G2APLA2G4ACDC14BCDC14A | |
| SCHEMBL22817657 | 1.00 | ALOX5 (0.34) | ALOX5PLA2G2APLA2G4ACDC14BCDC14A | |
| SCHEMBL22818355 | 0.99 | ALOX5 (0.35) | ALOX5PLA2G2APLA2G4ACDC14BCDC14A | |
| SCHEMBL22817991 | 0.99 | ALOX5 (0.35) | ALOX5PLA2G2APLA2G4ACDC14BCDC14A | |
| SCHEMBL22817671 | 0.99 | ALOX5 (0.35) | ALOX5PLA2G2APLA2G4ACDC14BCDC14A | |
| SCHEMBL22817634 | 0.98 | ALOX5 (0.33) | ALOX5PLA2G2APLA2G4ACDC14BCDC14A | |
| SCHEMBL22817832 | 0.96 | ALOX5 (0.36) | ALOX5PLA2G2APLA2G4APLA2G10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024111923-A1 | ORGANIC LIGHT-EMITTING DEVICE, AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER | 엘티소재주식회사 | 2024-05-30 | — | — | WO | disclosed |
| US-11812623-B2 | Hetero-cyclic compound and organic light emitting device using the same | LT MATERIALS CO., LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-11812623-B2 | Hetero-cyclic compound and organic light emitting device using the same | LT MATERIALS CO., LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-20230329025-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230329025-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-10-12 | — | — | US | disclosed |
| WO-2023096225-A1 | HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER, COMPRISING SAME | 엘티소재주식회사 | 2023-06-01 | — | — | WO | disclosed |
| US-20200403157-A1 | HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LT MATERIALS CO., LTD. (KR) | 2020-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11812623-B2 | Hetero-cyclic compound and organic light emitting device using the same | CRY1, CRY2, PER2 | ALOX5 1385/4885PLA2G2A 4271/4885PLA2G4A 3979/4885 |
| US-20200403157-A1 | HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CRY1, CRY2, PER2 | ALOX5 1385/4885PLA2G2A 4271/4885PLA2G4A 3979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.